Conidiobolus incongruus
Conidiobolus incongruus is a species of fungus in the family Ancylistaceae. It is a member of the genus Conidiobolus, which is known for its pathogenic properties in insects and other small invertebrates.
Taxonomy[edit]
The species was first described in the scientific literature by the mycologist R.F. Castañeda in 1987. The genus name Conidiobolus derives from the Greek words for 'dust' (konis) and 'throw' (bolos), referring to the way these fungi disperse their spores. The species name incongruus means 'inconsistent' or 'incongruous', possibly referring to some unique or unusual characteristic of this species.
Description[edit]
Like other members of the genus, Conidiobolus incongruus produces conidia, a type of asexual spore common in fungi. The conidia of C. incongruus are typically spherical or slightly elongated, and are produced in large numbers on the ends of specialized hyphae called conidiophores.
Habitat and distribution[edit]
Conidiobolus incongruus is found in a variety of habitats, including soil, decaying plant material, and the bodies of dead insects. It has been reported from various locations around the world, including North and South America, Europe, and Asia.
Pathogenicity[edit]
Conidiobolus incongruus is known to be a pathogen of insects and other small invertebrates. It infects its hosts by producing enzymes that break down the host's cell walls, allowing the fungus to invade the host's tissues. The fungus then reproduces by producing conidia, which are released into the environment when the host dies.
Research[edit]
Research into Conidiobolus incongruus and other related species is ongoing, with scientists interested in their potential use in biological control of pest insects and their role in natural ecosystems.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
